⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14790973 | 0.85 | — | — | |
| SCHEMBL9918184 | 0.80 | SHBG (0.33) | — | |
| SCHEMBL9921749 | 0.78 | — | — | |
| SCHEMBL14790975 | 0.77 | SHBG (0.38) | — | |
| SCHEMBL9918259 | 0.77 | SHBG (0.43) | — | |
| SCHEMBL9918820 | 0.77 | SHBG (0.43) | — | |
| SCHEMBL9918263 | 0.75 | SHBG (0.46) | — | |
| SCHEMBL9918260 | 0.75 | SHBG (0.46) | — | |
| SCHEMBL14791093 | 0.73 | SHBG (0.37) | — | |
| SCHEMBL14794979 | 0.68 | TSHR (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130071415-A1 | Heterocyclic Compounds as Janus Kinase Inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2013-03-21 | — | — | US | disclosed |
| US-20120149662-A1 | Heterocyclic Compounds as Janus Kinase Inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120149662-A1 | Heterocyclic Compounds as Janus Kinase Inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2012-06-14 | — | — | US | disclosed |